Strong evidence lacking to compare management strategies for renal artery stenosis

Researchers found a lack of strong evidence to compare the benefits and harms of revascularization using percutaneous transluminal renal angioplasty with stent placement (PTRAS) versus medical therapy alone for atherosclerotic renal artery stenosis (ARAS). The report is published in Annals of Internal Medicine.

ARAS is a narrowing of arteries that carry blood to one or both of the kidneys. It is more prevalent in older people and can lead to hypertension and kidney damage. Treatment options for ARAS include - aggressive blood pressure control, statins, and antiplatelets - or renal artery revascularization with continued medical therapy. PTRAS is the current standard for revascularization. A 2007 systematic review of management strategies for ARAS concluded that evidence did not support one treatment approach over another. Since then, two large trials have been conducted. Given the inconclusive prior review and the availability of new evidence, investigators sought to reevaluate the comparative benefits and harms of strategies for management of patients with ARAS and to identify factors that may predict which patients are most likely to benefit from each intervention.

The researchers reviewed 83 published studies to compare the benefits and harms of PTRAS versus medical therapy alone for ARAS. Overall, the evidence did not support a benefit with PTRAS over medical therapy alone in most patients with ARAS. Observational studies did suggest that some high risk patients may have improved outcomes with PTRA and anecdotal evidence suggest that some with acute decompensation due to ARAS benefit clinically from revascularization. A reanalysis of available research or more targeted studies may be needed to determine the comparative effectiveness of the two interventions.

Explore further

Beta-blockers following angioplasty show little benefit for some older patients

More information: Annals of Internal Medicine,
Journal information: Annals of Internal Medicine

Citation: Strong evidence lacking to compare management strategies for renal artery stenosis (2016, August 15) retrieved 12 December 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments